Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC
Viruses · 2023
DOI: 10.3390/v15051185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Shilei Ding und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada. Hauptthemen laut MEDLINE: HIV-1, HIV Seropositivity, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, P01-GM56550/AI150741.
Abstract (Originalsprache)
The ability of the HIV-1 accessory proteins Nef and Vpu to decrease CD4 levels contributes to the protection of infected cells from antibody-dependent cellular cytotoxicity (ADCC) by preventing the exposure of Env vulnerable epitopes. Small-molecule CD4 mimetics (CD4mc) based on the indane and piperidine scaffolds such as (+)-BNM-III-170 and (S)-MCG-IV-210 sensitize HIV-1-infected cells to ADCC by exposing CD4-induced (CD4i) epitopes recognized by non-neutralizing antibodies that are abundantly present in plasma from people living with HIV. Here, we characterize a new family of CD4mc, (S)-MCG-IV-210 derivatives, based on the piperidine scaffold which engages the gp120 within the Phe43 cavity by targeting the highly conserved Asp368 Env residue. We utilized structure-based approaches and developed a series of piperidine analogs with improved activity to inhibit the infection of difficult-to-neutralize tier-2 viruses and sensitize infected cells to ADCC mediated by HIV+ plasma. Moreover, the new analogs formed an H-bond with the α-carboxylic acid group of Asp368, opening a new avenue to enlarge the breadth of this family of anti-Env small molecules. Overall, the new structural and biological attributes of these molecules make them good candidates for strategies aimed at the elimination of HIV-1-infected cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.
- Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3T 1J4, Canada.
- Department of Chemical and Biological Engineering, Drexel University, Philadelphia, PA 19104, USA.
ORCID-Profile: Daniel Lee, Mohammadjavad Mohammadi, Marzena Pazgier
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- P01-GM56550/AI150741
- Canadian Institutes of Health Research (CIHR)
- CIHR team
- Canada Foundation for Innovation (CFI)
- National Institutes of Health
- 1UM1AI164562-01
Zitieren
APA
Ding, S., Tolbert, W. D., Zhu, H., Lee, D., Marchitto, L., Higgins, T., Zhao, X., Nguyen, D., Sherburn, R., Richard, J., Gendron-Lepage, G., Medjahed, H., Mohammadi, M., Abrams, C., Pazgier, M., Smith, A. B., & Finzi, A. (2023). Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Viruses. https://doi.org/10.3390/v15051185
Vancouver
Ding S, Tolbert WD, Zhu H, Lee D, Marchitto L, Higgins T, et al. Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Viruses. 2023. doi:10.3390/v15051185
BibTeX
@article{Ding2023,
author = {Ding, Shilei and Tolbert, William D and Zhu, Huile and Lee, Daniel and Marchitto, Lorie and Higgins, Tyler and Zhao, Xuchen and Nguyen, Dung and Sherburn, Rebekah and Richard, Jonathan and Gendron-Lepage, Gabrielle and Medjahed, Halima and Mohammadi, Mohammadjavad and Abrams, Cameron and Pazgier, Marzena and Smith, Amos B and Finzi, Andrés},
title = {Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15051185}
}
EUVIMED